Scleromyxedema (SM) is an uncommon disease with mucin deposition and fibroblast proliferation in the upper dermis. SM is a clinical variant of lichen myxedematosus and is characterized by a diffuse sclerodemic-like induration of the skin in addition to a peculiar lichenoid papular eruption. Usually, SM has a chronic and progressive course, sometimes with systemic involvement. In most cases the response to treatment is poor. A case of a 50-year old woman with cutaneous SM in association with esophageal aperistalsis, myopathy, and mild cardio-pulmonary involvement is reported. Seric CPK was elevated. Treatment with prednisone and cyclophosphamide led to an improvement of cutaneous and muscular symptomatology.

Scleromyxedema: A case report

Patruno C.;
1996-01-01

Abstract

Scleromyxedema (SM) is an uncommon disease with mucin deposition and fibroblast proliferation in the upper dermis. SM is a clinical variant of lichen myxedematosus and is characterized by a diffuse sclerodemic-like induration of the skin in addition to a peculiar lichenoid papular eruption. Usually, SM has a chronic and progressive course, sometimes with systemic involvement. In most cases the response to treatment is poor. A case of a 50-year old woman with cutaneous SM in association with esophageal aperistalsis, myopathy, and mild cardio-pulmonary involvement is reported. Seric CPK was elevated. Treatment with prednisone and cyclophosphamide led to an improvement of cutaneous and muscular symptomatology.
1996
Lichen myxedematosus
Scleromyxedema
Therapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12317/64061
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact